SCHEMBL20853261

SCHEMBL20853261

C=Cc1cc2ccccc2n1CC(=C)CC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.37
TP53 P04637 2/20 0.37
MTNR1A P48039 3/20 0.36
MTNR1B P49286 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 2/20 0.34
THRB P10828 1/20 0.34
ABCC2 Q92887 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
CCR2 P41597 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NOD2 Q9HC29 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20853323 0.81 CA12 (0.39) TSHRTP53MTNR1AMTNR1BL3MBTL1
SCHEMBL20853244 0.77 ABCC2 (0.47) TSHRL3MBTL1KMT2AMEN1ABCC2
SCHEMBL20853229 0.74 KDM4E (0.40) TSHRTP53L3MBTL1KMT2AMEN1
SCHEMBL27366620 0.74 CNR2 (0.45) TSHRTP53L3MBTL1POLBABCC2
SCHEMBL20853006 0.72 CCR2 (0.54) L3MBTL1KMT2AMEN1CCR2KDM4E
SCHEMBL20853230 0.71 PPARG (0.46) CCR2KDM4ENOD2NOD1ALDH1A1
SCHEMBL20853220 0.70 CNR2 (0.40) TSHRKMT2AMEN1KDM4EALDH1A1
SCHEMBL20937290 0.69 CCR2 (0.56) TSHRKMT2AMEN1POLBCCR2
SCHEMBL7971398 0.69 GRIN2D (0.51) KMT2AMEN1ABCC2GRIN2DGRIN3B
SCHEMBL20853004 0.68 L3MBTL1 (0.50) TSHRTP53L3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019058393-A1 HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS JUBILANT BIOSYS LIMITED (IN) 2019-03-28 WO disclosed